MeadowBrook Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Hold
1,800
0.13% 115
2026
Q1
$153K Hold
1,800
0.14% 117
2025
Q4
$142K Hold
1,800
0.12% 138
2025
Q3
$144K Hold
1,800
0.12% 135
2025
Q2
$164K Hold
1,800
0.15% 123
2025
Q1
$169K Hold
1,800
0.16% 120
2024
Q4
$164K Hold
1,800
0.15% 122
2024
Q3
$187K Hold
1,800
0.17% 110
2024
Q2
$175K Hold
1,800
0.17% 114
2024
Q1
$162K Hold
1,800
0.15% 120
2023
Q4
$143K Buy
+1,800
New +$135K 0.14% 127

Other funds holding CL

MeadowBrook Investment Advisors's CL Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its Colgate-Palmolive (CL) position steady in Q2 2026 at 1,800 shares worth $165K. The position accounts for 0.13% of the portfolio, ranked #115.

MeadowBrook Investment Advisors first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $187K in Q3 2024. 708 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • MeadowBrook Investment Advisors held 1,800 shares of Colgate-Palmolive worth $165K as of Q2 2026.
  • MeadowBrook Investment Advisors left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.13% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #115 holding.
  • MeadowBrook Investment Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Colgate-Palmolive position peaked at $187K in Q3 2024.
  • 708 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.